Search results
Results from the WOW.Com Content Network
Many people with SLL live for far longer. Some people diagnosed in their 60s and 70s could very well live normal life spans. Even if treatment is needed, the 10-year survival rate for small lymphocytic lymphoma hovers at around 84% if you do not relapse during the first five years.
SLL is a slow-growing cancer of white blood cells that affects the lymph nodes. Learn about the risk factors, diagnosis, and treatment options, including chemotherapy, monoclonal antibodies, and...
The five-year survival rate for SLL in the United States is 86.9 percent. This means that, for every 100 people diagnosed with SLL now, about 87 people are expected to be alive in five years. This survival rate also applies to people with CLL. Treatment options for SLL are constantly improving.
SLL stands for small lymphocytic lymphoma, a slow-growing cancer of B-lymphocytes that affects the lymph nodes and spleen. Learn about the causes, symptoms, diagnosis, treatment, and prognosis of SLL.
Small lymphocytic lymphoma (SLL) is a type of cancer that happens when your body makes too many abnormal versions of a type of white blood cell called B lymphocytes. SLL is usually...
In the United States, about 5.8 per 100,000 males and 3.3 per 100,000 females develop CLL or SLL a year. CLL and SLL are treated the same. People who receive a diagnosis of these cancers generally...
Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) is an indolent malignancy characterized by increased production of mature but dysfunctional B lymphocytes.
Using statistical models for analysis, age-adjusted rates for new chronic lymphocytic leukemia/small lymphocytic lymphoma cases have been falling on average 1.2% each year over 2012–2021. Age-adjusted death rates have been stable over 2012–2021. 5-year relative survival trends are shown below.
Cancer Stat Facts: NHL — Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — National Cancer Institute; Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma — American Cancer Society; How Is Chronic Lymphocytic Leukemia Staged? — American Cancer Society; CLL Staging — Leukemia & Lymphoma ...
For HL, overall, the five-year survival rate is 87%. This means that at initial diagnosis, overall those diagnosed with HL are about 87% likely as those without the diagnosis to live five years after diagnosis.